E2007-A001-040 * Bioequivalence - Multi-dose n/a Bioavailability - Single dose E2007-E044-017 * E2007-E044-028 * Food effect Single dose E2007-E044-003 * – * PK in special Target population populations - Single dose n/a PK in special E2007-E049-203 § populations - Multi-dose Hepatic impairment E2007-E044-015 * Renal impairment n/a Paediatrics and adolescents n/a Elderly E2007-E044-007 * Single dose – Poly-substance users E2007-A001-023 * E2007-A001-024 * Gender- Males versus females E2007-E044-003 * PK PK Ketoconazole E2007-E044-005 * interactions PK Carbamazepine E2007-E044-006 * interactions Midazolam E2007-A001-014 * Oral contraceptives E2007-E044-019 * E2007-E044-029 * Levodopa E2007-E044-025 * Population Healthy subjects * PK analyses Population Target population EMFFR2008/06/00b § PK analyses Adults (Phase II) CPMS-E2007-2011-003c §
E2007-A001-040 * Bioequivalence - Multi-dose n/a Bioavailability - Single dose E2007-E044-017 E2007-E044-028 * * Food effect – Single dose E2007-E044-003 * * PK in special populations Target population - Single dose n/a PK in special populations - Multi-dose E2007-E049-203 § Hepatic impairment E2007-E044-015 * Renal impairment n/a Paediatrics and adolescents n/a Elderly – Single dose E2007-E044-007 * Poly-substance users E2007-A001-023 E2007-A001-024 * * PK Males versus females E2007-E044-003 * PK interactions Ketoconazole E2007-E044-005 * PK interactions Carbamazepine E2007-E044-006 * Midazolam E2007-A001-014 * Oral contraceptives E2007-E044-019 E2007-E044-029 * * Levodopa E2007-E044-025 * Population PK analyses Healthy subjects * Population PK analyses Target population Adults (Phase II) EMFFR2008/06/00b CPMS-E2007-2011-003c § § Gender-
auspar-perampanel-141014-cer.docx